Details for Patent: 7,449,458
✉ Email this page to a colleague
Which drugs does patent 7,449,458 protect, and when does it expire?
Patent 7,449,458 protects TAVALISSE and is included in one NDA.
This patent has thirty-eight patent family members in twenty-nine countries.
Summary for Patent: 7,449,458
| Title: | Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
| Abstract: | The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds of structural formula shown below, compositions comprising these compounds, intermediates and methods for synthesizing these compounds, and methods for using these compounds in a variety of applications including treatment of autoimmune diseases. ##STR00001## |
| Inventor(s): | Bhamidipati; Somasekhar (Foster City, CA), Singh; Rajinder (Belmont, CA), Stella; Valentino J. (Lawrence, KS), Sun; Thomas (Fremont, CA) |
| Assignee: | Rigel Pharmaceuticals, Inc. (South San Francisco, CA) |
| Application Number: | 11/337,049 |
|
Patent Claim Types: see list of patent claims | Compound; |
Drugs Protected by US Patent 7,449,458
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rigel Pharms Inc | TAVALISSE | fostamatinib disodium | TABLET;ORAL | 209299-001 | Apr 17, 2018 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Rigel Pharms Inc | TAVALISSE | fostamatinib disodium | TABLET;ORAL | 209299-002 | Apr 17, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,449,458
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | E451381 | ⤷ Try a Trial | |||
| Australia | 2006206458 | ⤷ Try a Trial | |||
| Brazil | PI0606318 | ⤷ Try a Trial | |||
| Canada | 2591948 | ⤷ Try a Trial | |||
| China | 101115761 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
